Početna › Autoimune bolesti › Minnesota
Kliničke studije za Autoimune bolesti u državi Minnesota
9 studija za Autoimune bolesti traži sudionike na lokacijama u državi Minnesota.
Gradovi u državi Minnesota
Službeni tekst studije (engleski)
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
- National Marrow Donor Program, Minneapolis
U tijeku regrutacijaFaza 2Zdravi dobrovoljci dobrodošli
Od 4 do 75 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT02579967RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Mayo Clinic - Accepting Adult Patients, Rochester
U tijeku regrutacijaFaza 2/3
Od 6 do 75 godina · Oba spola · Ažurirano 17. ruj 2026. · NCT06154252Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
- Mayo Clinic: Division of Rheumatology, Rochester
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 17. ruj 2026. · NCT07103746RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of Minnesota, Minneapolis
U tijeku regrutacijaFaza 1/2
Od 18 do 65 godina · Oba spola · Ažurirano 26. kol 2026. · NCT06121297Abatacept for the Treatment of Giant Cell Arteritis
- Mayo Clinic, Rochester
U tijeku regrutacijaFaza 3
Od 50 godina i više · Oba spola · Ažurirano 20. kol 2026. · NCT04474847RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Mayo Clinic Rochester, Rochester
U tijeku regrutacijaFaza 2/3
Od 18 do 75 godina · Oba spola · Ažurirano 17. kol 2026. · NCT06328777RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Mayo Clinic - Rochester, Rochester
U tijeku regrutacijaFaza 1/2
Od 18 do 70 godina · Oba spola · Ažurirano 13. kol 2026. · NCT06359041A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- University of Minnesota Medical School, Minneapolis
U tijeku regrutacijaFaza 1
Od 12 do 70 godina · Oba spola · Ažurirano 22. svi 2026. · NCT06308978A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
- University of Minnesota Delaware Clinical Research Unit, Minneapolis
- Mayo Clinic, Rochester
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 25. velj 2026. · NCT06626919Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.